Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unfolding heterochromatin for replication

Ivana L de la Serna, Anthony N Imbalzano

    Nature Genetics
    |November 29, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reciprocal regulation between the protein arginine deiminases and mSWI/SNF chromatin remodelers controls skeletal muscle differentiation and regeneration.

    bioRxiv : the preprint server for biology·2026
    Same author

    <i>Tceal7</i> is a BRG1-regulated target of calcineurin signaling that promotes myoblast differentiation.

    bioRxiv : the preprint server for biology·2026
    Same author

    Transcription Elongation Factor A (SII)-Like (TCEAL) Family Members: Re-Evaluation of Predicted Structure and Summary of Expression and Functions.

    Critical reviews in eukaryotic gene expression·2025
    Same author

    YAP1 drives aggressive and therapy resistant state in melanoma through reprogramming the chromatin and regulating immune evasive programs.

    bioRxiv : the preprint server for biology·2025
    Same author

    Ablation of the Evolutionarily Acquired Functions of the <i>Atp1b4</i> Gene Increases Metabolic Capacity and Reduces Obesity.

    Life (Basel, Switzerland)·2025
    Same author

    Death-ision: the link between cellular resilience and cancer resistance to treatments.

    Molecular cancer·2025